A focus on expanding domestic sales of TDM-621 by converting the reduced cost burden for medical institutions resulting from approval for insurance coverage in Japan into faster sales growth. This also includes sales stagnation caused by rejected reimbursement claims and a slowdown in acquiring new customers.